Saturday, 17 October 2026European Markets
ExploreSearch
ViaNews EU
stockMarket

DISTRI-LAND CERT Stock Was Up By 9.62% On Tuesday

Loading stream...

(VIANEWS) - The Market ended the session with DISTRI-LAND CERT (DISL.BR) rising 9.62% to €228.00 on Tuesday while BEL 20 fell 0.12% to €3,845.42.

About DISTRI-LAND CERT

Immobiliere Distri-Land NV engages in the issuing and managing of real estate certificates. The company was incorporated in 1989 and is based in Sint-Jans-Molenbeek, Belgium. Immobiliere Distri-Land NV operates as a subsidiary of KBC Bank NV.

Earnings Per Share

As for profitability, DISTRI-LAND CERT has a trailing twelve months EPS of €7.55.

PE Ratio

DISTRI-LAND CERT has a trailing twelve months price to earnings ratio of 30.2. Meaning, the purchaser of the share is investing €30.2 for every euro of annual earnings.

Volume

Today's last reported volume for DISTRI-LAND CERT is 6 which is 100% above its average volume of 3.

More news about DISTRI-LAND CERT (DISL.BR).

Categories

stockMarket

Tags

Market-Close NowStock PriceClosesStock Market NowEnd of DayDISL.BRPrice UpMarket CloseStock Price UpDISTRI-LAND CERTStock MarketStock
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,384 source documents archived
Query this data → isubstrate.com